RESO101NCT07602426
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of resO™ Bone and Joint Support Postbiotic on Physical Function, Pain Interference, and Mobility in Adults With Joint Discomfort
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Minor Trial completed
- Primary completion date changed from estimate of May 15, 2026 to Jun 2, 2026
- Study completion date changed from estimate of May 31, 2026 to Jun 2, 2026
- Secondary endpoints: details revised at 2 of 3 entries
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Change From Baseline to Week 4 in PROMIS Physical Function T-score
Timeframe: Baseline and Week 4
Changes in gut microbiota composition associated with bone health
Timeframe: 8 weeks
Change From Baseline to Week 4 in PROMIS Pain Interference T-score
Timeframe: Baseline and Week 4
Secondary (3)
Change From Baseline to Week 4 in Pain Intensity Numeric Rating Scale (NRS) Score
Change From Baseline to Week 4 in Duke Activity Status Index (DASI) Score
Change From Baseline to Week 4 in International Physical Activity Questionnaire-Short Form (IPAQ-SF) MET-minutes/week
Arms and interventions
PlaceboPlacebo comparator
SupplementExperimental
Other: Placebo
Dietary supplements: Supplement
Sites
1 site in 1 country
- Able Biolabs LLCDallas, Texas, United States